Skip to main navigation Skip to search Skip to main content

Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation (Analytical Methods (2025) 17 (6215-6230) DOI: 10.1039/D5AY00698H)

  • Samar M. Mahgoub
  • , Abdullah S. Alawam
  • , Hassan A. Rudayni
  • , Ahmed A. Allam
  • , Khaled Hesham Ezzat
  • , Saber A.A. Elsuccary
  • , Abdelatty M. Radalla
  • , Rehab Mahmoud

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors sincerely apologise for providing an incorrect grant number in their Acknowledgements. The correct attribution of their funding is as follows: This work was supported and funded by the Deanship of Scientiflc Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) (grant number IMSIU-DDRSP2501). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Original languageEnglish
Pages (from-to)7126
Number of pages1
JournalAnalytical Methods
Volume17
Issue number35
DOIs
Publication statusPublished - Sept 11 2025

ASJC Scopus subject areas

  • Analytical Chemistry
  • General Chemical Engineering
  • General Engineering

Fingerprint

Dive into the research topics of 'Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation (Analytical Methods (2025) 17 (6215-6230) DOI: 10.1039/D5AY00698H)'. Together they form a unique fingerprint.

Cite this